CLOV
Price
$3.34
Change
+$0.02 (+0.60%)
Updated
May 2 closing price
Capitalization
381.23M
2 days until earnings call
CTAS
Price
$211.55
Change
+$2.00 (+0.95%)
Updated
May 2 closing price
Capitalization
69.7B
68 days until earnings call
Ad is loading...

CLOV vs CTAS

Header iconCLOV vs CTAS Comparison
Open Charts CLOV vs CTASBanner chart's image
Clover Health Investments
Price$3.34
Change+$0.02 (+0.60%)
Volume$5.01M
Capitalization381.23M
Cintas
Price$211.55
Change+$2.00 (+0.95%)
Volume$1.37M
Capitalization69.7B
CLOV vs CTAS Comparison Chart
Loading...
CLOV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CTAS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLOV vs. CTAS commentary
May 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLOV is a Hold and CTAS is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 04, 2025
Stock price -- (CLOV: $3.34 vs. CTAS: $211.55)
Brand notoriety: CLOV and CTAS are both not notable
CLOV represents the Managed Health Care, while CTAS is part of the Miscellaneous Commercial Services industry
Current volume relative to the 65-day Moving Average: CLOV: 89% vs. CTAS: 68%
Market capitalization -- CLOV: $381.23M vs. CTAS: $69.7B
CLOV [@Managed Health Care] is valued at $381.23M. CTAS’s [@Miscellaneous Commercial Services] market capitalization is $69.7B. The market cap for tickers in the [@Managed Health Care] industry ranges from $451.47B to $0. The market cap for tickers in the [@Miscellaneous Commercial Services] industry ranges from $80.94B to $0. The average market capitalization across the [@Managed Health Care] industry is $68.32B. The average market capitalization across the [@Miscellaneous Commercial Services] industry is $5.41B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLOV’s FA Score shows that 0 FA rating(s) are green whileCTAS’s FA Score has 2 green FA rating(s).

  • CLOV’s FA Score: 0 green, 5 red.
  • CTAS’s FA Score: 2 green, 3 red.
According to our system of comparison, CTAS is a better buy in the long-term than CLOV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLOV’s TA Score shows that 4 TA indicator(s) are bullish while CTAS’s TA Score has 5 bullish TA indicator(s).

  • CLOV’s TA Score: 4 bullish, 3 bearish.
  • CTAS’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, CTAS is a better buy in the short-term than CLOV.

Price Growth

CLOV (@Managed Health Care) experienced а -2.62% price change this week, while CTAS (@Miscellaneous Commercial Services) price change was +1.51% for the same time period.

The average weekly price growth across all stocks in the @Managed Health Care industry was +0.10%. For the same industry, the average monthly price growth was -4.93%, and the average quarterly price growth was -0.68%.

The average weekly price growth across all stocks in the @Miscellaneous Commercial Services industry was +4.27%. For the same industry, the average monthly price growth was +6.01%, and the average quarterly price growth was +8.03%.

Reported Earning Dates

CLOV is expected to report earnings on Aug 11, 2025.

CTAS is expected to report earnings on Jul 10, 2025.

Industries' Descriptions

@Managed Health Care (+0.10% weekly)

Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.

@Miscellaneous Commercial Services (+4.27% weekly)

The sector produces general business services, and are not classified elsewhere. For example, FleetCor Technologies provides fuel cards and workforce payment products and services; Copart, Inc. provides online vehicle auction and remarketing services across various nations; Equifax Inc. collects and aggregates credit information on consumers and businesses worldwide, along with selling credit monitoring and fraud-prevention services. Many of the companies in this category have multi-billion market capitalizations.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CTAS($69.7B) has a higher market cap than CLOV($381M). CTAS YTD gains are higher at: 16.011 vs. CLOV (6.032). CTAS has higher annual earnings (EBITDA): 2.34B vs. CLOV (-210.84M). CLOV has less debt than CTAS: CLOV (4.66M) vs CTAS (2.87B). CTAS has higher revenues than CLOV: CTAS (9.19B) vs CLOV (2.03B).
CLOVCTASCLOV / CTAS
Capitalization381M69.7B1%
EBITDA-210.84M2.34B-9%
Gain YTD6.03216.01138%
P/E RatioN/A49.26-
Revenue2.03B9.19B22%
Total Cash243MN/A-
Total Debt4.66M2.87B0%
FUNDAMENTALS RATINGS
CTAS: Fundamental Ratings
CTAS
OUTLOOK RATING
1..100
19
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
4
SMR RATING
1..100
25
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
43
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLOVCTAS
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
36%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
63%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
63%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
65%
Advances
ODDS (%)
Bullish Trend 10 days ago
81%
Bullish Trend 4 days ago
63%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 6 days ago
37%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 6 days ago
35%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
CLOV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CTAS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PRQR1.990.27
+15.70%
ProQR Therapeutics NV
PRKS45.911.10
+2.45%
United Parks & Resorts
NEUP5.050.05
+1.10%
Neuphoria Therapeutics Inc
ROL56.670.60
+1.07%
Rollins
SBR65.12-0.50
-0.76%
Sabine Royalty Trust

CTAS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTAS has been loosely correlated with EXPO. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if CTAS jumps, then EXPO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTAS
1D Price
Change %
CTAS100%
+0.95%
EXPO - CTAS
62%
Loosely correlated
-1.34%
DNB - CTAS
51%
Loosely correlated
+0.34%
ARLO - CTAS
47%
Loosely correlated
+2.58%
VRSK - CTAS
47%
Loosely correlated
-0.21%
RELX - CTAS
47%
Loosely correlated
+1.74%
More